1.10Open0.71Pre Close472 Volume394 Open Interest87.00Strike Price38.26KTurnover66.77%IV6.43%PremiumAug 30, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.74Extrinsic Value100Contract SizeAmericanOptions Type0.2468Delta0.0519Gamma95.86Leverage Ratio-0.2236Theta0.0024Rho23.66Eff Leverage0.0287Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.